Panangin forte film-coated tablets 280 mg/316 mg 60 pieces

1 film-coated tablet contains:

280 mg of magnesium asparaginate (as 350 mg of magnesium asparaginate tetrahydrate);

316 mg of potassium asparaginate (as 332.6 mg of potassium asparaginate hemihydrate);

excipients: colloidal anhydrous silicon dioxide; povidone K-30; potato starch; magnesium stearate; talc; corn starch;

film coating: macrogol 6000; titanium dioxide (E 171); butylated methacrylate copolymer (Eudragit E); talc.

• hypersensitivity to the active substances or to any of the excipients of the drug;
• acute or chronic renal failure;
• Addison’s disease;
• atrioventricular block III degree;
• cardiogenic shock (blood pressure < 90 mm Hg);

For internal use.

The recommended daily dose is 1 tablet 3 times a day.

The maximum daily dose is 1 tablet 3 times a day.

The course of treatment is determined by the doctor.

Gastric juice may reduce the effectiveness of the drug, so it is recommended to take Panangin Forte after meals.

Pregnant women

Use during pregnancy or breastfeeding.

To date, there is no data on any harmful effects when using the drug Panangin Forte in this category of patients.

Children

The safety and efficacy of Panangin Forte film-coated tablets in children and adolescents have not been established. The drug is not recommended for use in this group of patients.

Drivers

Panangin Forte does not affect the ability to drive vehicles and other mechanisms.

Large doses of Panangin Forte may cause an increase in bowel movements due to the magnesium content.

Symptoms of hyperkalemia: general weakness, paresthesias, bradycardia, paralysis. Extremely high plasma potassium concentrations can lead to death from cardiac depression, arrhythmia, or cardiac arrest.

Symptoms of hypermagnesemia: nausea, vomiting, drowsiness, hypotension, bradycardia, weakness, slurred speech, double vision. At very high plasma concentrations of magnesium, hyporeflexia, muscle paralysis, respiratory arrest and cardiac arrest may develop.

Treatment.

In case of overdose, the drug should be discontinued and, if necessary, symptomatic treatment should be carried out (intravenous calcium chloride, dialysis if necessary).

On the part of the gastrointestinal tract: when using large doses of the drug, an increase in the frequency of bowel movements is possible.

According to some reports, nausea, vomiting, and abdominal pain may occur.

Store at a temperature not exceeding 30 ºС in the original packaging.

Keep out of reach of children.

Shelf life – 2 years.